Gyre Therapeutics, Inc. (GYRE)
Nasdaq: GYRE · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2002
Grade5.2
◀ Past 4.5● Present 5.9▶ Future 4.9
Who runs Gyre Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Luo Ying
Chief Executive Officer. First filing Jan 2023, latest Jun 10, 2026, 1 filing in all.
Officers reporting now
7
of 15 people with a filing in the last fifteen months
Directors reporting now
8
35 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Ye Weiguo | Chief Operating Officer | Nov 2023 | Jun 22, 2026 | 16 · $900,000 |
| Luo Ying | Chief Executive Officer | Jan 2023 | Jun 10, 2026 | 2 · $100,000 |
| Bergmann Joshua Benjamin | GC and Corporate Secretary | May 2026 | Jun 10, 2026 | none |
| Xiong Yue | Chief Scientific Officer | May 2026 | May 7, 2026 | none |
| Wang Jialiang (Nmn) | EVP, General Manager | May 2026 | May 7, 2026 | none |
| Eastling Thomas Wilson | Chief Financial Officer | Jan 2023 | May 6, 2026 | none |
| Chen Ruoyu | Chief Financial Officer | Nov 2023 | Jan 9, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kirkby Maxwell | director | Aug 2026 | Aug 4, 2026 | none |
| Weston Claire | director | Aug 2026 | Aug 4, 2026 | none |
| Carmichael Gordon | director | Nov 2023 | Jun 30, 2026 | none |
| Epstein David M. | director | Aug 2024 | Jun 30, 2026 | none |
| Nussbaum Rodney L | director | Mar 2024 | Jun 30, 2026 | none |
| Parry Renate | director | Nov 2023 | Jun 30, 2026 | none |
| Weng Dan | director | Aug 2025 | Jun 30, 2026 | none |
| Zhang Ping | director | Jan 2025 | Jun 30, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Gni Group Ltd. | 10% owner | Jan 2023 | May 6, 2026 | none |
| Gni Usa, Inc. | 10% owner | Oct 2023 | May 6, 2026 | none |
Earlier names on the record27, newest filing first
Ma Songjiang · officer · last filing May 2025Ying Han · officer · last filing Aug 2024Usman Nassim · officer · last filing Jul 2024Wu Charles C · officer · last filing Nov 2023Gni Hong Kong Ltd · 10% owner · last filing Oct 2023Miller Seline E. · officer · last filing Sep 2023Hunt Andrea · director · last filing Sep 2023Lawlor Augustine · director · last filing Sep 2023Blouse Grant E. · officer · last filing Aug 2022Ling Geoffrey M.D. · director · last filing Jan 2022Williams Eddie · director · last filing Jan 2022Desouza Errol B · director · last filing Oct 2021Jew Jeanne Y · director · last filing Sep 2021Levy Howard · officer · last filing Aug 2021Tetlow Sharon · director · last filing Jul 2021Musil Clinton · officer · last filing Apr 2021Cai Veronica · officer · last filing Mar 2020Richard John P · director · last filing Mar 2020Payne Fletcher · officer · last filing Sep 2019Hill Stephen A · officer · last filing Sep 2018Jfl Capital Management, LLC · other · last filing Jul 2018Deerfield Management Company, L.P. (Series C) · 10% owner · last filing Mar 2018Deerfield Mgmt L.P. · 10% owner · last filing Mar 2018Deerfield Partners, L.P. · 10% owner · last filing Mar 2018Deerfield Special Situations Fund, L.P. · 10% owner · last filing Mar 2018Flynn James E · 10% owner · last filing Mar 2018Selick Harold E · director · last filing Jan 2018
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.